#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Raynaud's phenomenon Acute lymphocytic leukaemia recurrent Netherton's syndrome Malignant oligodendroglioma Mantle cell lymphoma stage II Oesophageal squamous cell carcinoma Neuropathic arthropathy Chronic kidney disease Uterine leiomyosarcoma Carcinoid syndrome Juvenile idiopathic arthritis Heart disease congenital Spinal cord injury Muscular dystrophy More trials…

    Learn about Rare Diseases

    Chordoma – Trials in Disease Nephrotic syndrome – Treatment Choroid melanoma – Diagnostics Usher’s syndrome – Diagnostics Netherton’s syndrome – Trials in Disease Hepatic angiosarcoma – Life with Disease Cholangitis sclerosing – Diagnostics Chronic granulomatous disease – Trials in Disease Ehlers-Danlos syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pegaspargase Toripalimab Clarithromycin Gallium Citrate Ga-68 Mk-1942 Ag-946 Zidesamtinib Alks 2680 Ixazomib Citrate Cariprazine Hydrochloride ZAMPILIMAB LUXDEGALUTAMIDE Fosphenytoin Sodium Radotinib Dihydrochloride Dydrogesterone 204-NETU Trospium Chloride Batoclimab F1245/05 Ribitol More therapies…

    Learn about Your Condition

    Foot deformity Amyotrophic lateral sclerosis Bile duct adenocarcinoma Glioma Piriformis syndrome Onychomycosis Cardiac disorder Dermatitis EGFR gene mutation Lung adenocarcinoma stage III Chondrosarcoma Cutaneous lupus erythematosus Giardiasis Laryngeal cancer stage I Ulcerative keratitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Follitropin Alfa
    France

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +5

  • Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Levoleucovorin
    • Irinotecan Hydrochloride Trihydrate
    • Capecitabine
    France

  • Study on Apixaban for Patients with Intrahepatic Non-Cirrhotic Portal Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    France

  • Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • Caplacizumab
    Austria Belgium Czechia France Germany Greece +3

  • Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Sorafenib
    • Tremelimumab
    • Durvalumab
    France Germany Italy Spain

  • Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tirbanibulin
    • Diclofenac Sodium
    France Germany Italy Poland Spain

  • Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone
    • Ciclosporin
    • Tacrolimus
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Methoxsalen
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    France Germany Italy Poland Spain
Previous Page
1 … 40 41 42 43 44 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!